SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-19-003232
Filing Date
2019-04-24
Accepted
2019-04-24 16:14:07
Documents
3
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 38497
2 GRAPHIC defa14ag001.gif GRAPHIC 131027
3 GRAPHIC defa14ag002.gif GRAPHIC 76272
  Complete submission text file 0001558370-19-003232.txt   325006
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 19763985
SIC: 2834 Pharmaceutical Preparations